Search over 3,000 reports

    Glomerulonephritis - Pipeline Insights, 2017

    Glomerulonephritis - Pipeline Insights, 2017
    Date: Dec, 2017
    Type: Pharmaceutical Industry Report
    Pages: 102
    Geography: Global
    Delivery Timeline: 24 Hours
    SKU: DIPI0143
    DelveInsight's, "Glomerulonephritis - Pipeline Insights, 2017", report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Glomerulonephritis. This report provides information on the therapeutic development for Glomerulonephritis dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the company's information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products. The report covers 25+ drugs.
    The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
    Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases
    Introduction
    Overview
    Pipeline Therapeutics
    Therapeutics under Development by Companies
    Last Stage Products (Phase III)
    Mid Stage Products (Phase II)
    Early Stage Products (Phase I)
    Pre-clinical and Discovery stage Products
    Unknown Stage Products
    Therapeutic Assessment
    Discontinued Products
    Dormant Products
    Companies Involved in Therapeutic Development
    Appendix
    Consulting Services
    About DelveInsight
    Contact Us
    Disclaimer
    Table 1:Number of Products Under Development for Glomerulonephritis
    Table 2: Number of Products under Development by Companies
    Table 3: Last Stage Products (Phase III)
    Table 4: Mid Stage Products (Phase II)
    Table 5: Early Stage Products (Phase I)
    Table 6: Pre-clinical and Discovery Stage Products
    Table 7: Unknown Stage Products
    Table 8: Assessment by Monotherapy Products
    Table 9: Assessment by Combination therapy Products
    Table 10: Assessment by Route Of Administration
    Table 11:Assessment by Stage and Route Of Administration
    Table 12:Assessment by Molecule Type
    Table 13: Assessment by Stage and Molecule Type
    Table 14: Discontinued Products
    Table 15:Dormant Products
    Table 16: Achillion Pharmaceuticals
    Table 17: Alexion Pharmaceuticals Inc.
    Table 18: Amyndas Pharmaceuticals SA
    Table continued?
    Table 35: Visterra Inc
    Figure 1: Glomerulo Nephritis
    Figure 2: Number of Products under Development for Glomerulonephritis
    Figure 3: Last Stage Products (Phase III)
    Figure 4: Mid Stage Products (Phase II)
    Figure 5: Early Stage Products (Phase I)
    Figure 6: Pre-clinical and Discovery Stage Products
    Figure 7: Unknown Stage Products
    Figure 8:Assessment by Monotherapy Products
    Figure 9:Assessment by Combination therapy Products
    Figure 10:Assessment by Route of Administration
    Figure 11: Assessment by Stage and Route of Administration
    Figure 12: Assessment by Molecule Type
    Figure 13 :Assessment by Stage and Molecule Type
    Figure 14:Discontinued Products
    Figure 15: Dormant Products
    Glomerulonephritis Pipeline Drugs

    Glomerulonephritis Pipeline Assessment

    Glomerulonephritis Pipeline Analysis

    Glomerulonephritis Drugs under Development

    Glomerulonephritis Discovery drugs

    Glomerulonephritis Preclinical drugs

    Glomerulonephritis Phase I drugs

    Glomerulonephritis Phase II drugs

    Glomerulonephritis Phase III Pipeline Drugs Assessment

    Glomerulonephritis Preregistration drugs

    Glomerulonephritis Molecules in pipeline

    • Single User License
      (20% Off)
      $1,250.00
    • Site License
      (30% Off)
      $2,500.00
    • Global License
      (40% Off)
      $4,000.00

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap